N. Varshney, V. Bhalla, and M. K. Gupta, “Technical reasons for delay and denial of regulatory approval of Initial applications for (Abbreviated) New Drugs filed by Indian Companies by USFDA, 2005-2022”, Int J Drug Reg Affairs, vol. 12, no. 1, pp. 54-60, Mar. 2024.